Detalhe da pesquisa
1.
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell
; 173(3): 624-633.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656892
2.
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Blood
; 137(10): 1353-1364, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871584
3.
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial.
Lancet Oncol
; 21(3): 358-372, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007138
4.
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.
Blood
; 130(22): 2420-2430, 2017 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893733
5.
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Blood
; 127(18): 2203-13, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773040
6.
Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Blood
; 127(7): 869-81, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702065
7.
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
Mol Pharmacol
; 90(5): 674-688, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573671
8.
ASSIGN: context-specific genomic profiling of multiple heterogeneous biological pathways.
Bioinformatics
; 31(11): 1745-53, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25617415
9.
RamiGO: an R/Bioconductor package providing an AmiGO visualize interface.
Bioinformatics
; 29(5): 666-8, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297033
10.
GeneSigDB: a manually curated database and resource for analysis of gene expression signatures.
Nucleic Acids Res
; 40(Database issue): D1060-6, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22110038
11.
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Oncoimmunology
; 13(1): 2290787, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170160
12.
iBBiG: iterative binary bi-clustering of gene sets.
Bioinformatics
; 28(19): 2484-92, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22789589
13.
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Nat Cancer
; 4(9): 1292-1308, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525015
14.
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i).
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728875
15.
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217575
16.
GCOD - GeneChip Oncology Database.
BMC Bioinformatics
; 12: 46, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21291543
17.
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.
Clin Cancer Res
; 27(16): 4500-4510, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108180
18.
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i.
Nat Med
; 26(10): 1557-1563, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020648
19.
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients.
J Immunother Cancer
; 6(1): 18, 2018 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510697
20.
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.
Sci Transl Med
; 10(450)2018 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021886